交易中 07-21 11:23:46 美东时间
+0.165
+1.52%
DLocal Limited (NASDAQ: DLO) intends to release its second fiscal quarter ended June 30, 2025 financial results on August 13, 2025 after market close. A conference call and video webcast will be held at 5:00 p.m. Eastern Time on the same day. Investors can pre-register for the call or access the webcast via the investor relations section of the Company’s website. The webcast will be archived for one year. About dLocal: dLocal enables global enter...
07-14 20:15
We wouldn't blame Nucor Corporation (NYSE:NUE) shareholders if they were a litt...
06-30 18:23
Insiders were net sellers of Stride, Inc.'s (NYSE:LRN ) stock during the past y...
06-30 18:00
Over the last year, a good number of insiders have significantly increased thei...
06-30 08:40
David Iben put it well when he said, 'Volatility is not a risk we care about. W...
06-27 21:01
Howard Marks put it nicely when he said that, rather than worrying about share ...
06-25 02:40
The excitement of investing in a company that can reverse its fortunes is a big...
06-25 02:12
dLocal appoints Will Pruett as an Independent Board Member and Audit Committee member, effective July 1, 2025. Pruett brings extensive expertise in capital markets and emerging markets, particularly in Latin America, Asia, and Africa. He previously served as a portfolio manager at Fidelity Investments and at HSBC. dLocal also announced the conclusion of Mariam Toulan's term as Independent Director on June 30, 2025. The company thanks her for her ...
06-23 20:05
Uruguay-based payment processing platform dLocal (NASDAQ:DLO) announced on Tuesday an intent to acquire the cross-border payments and foreign exchange solutions provider founded in Nairobi, AZA Financ...
06-03 22:35
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1136585934532136961.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Vera Therapeutics(VERA)"买入"评级,目标价从75美元升至85美元</p> <p>• Ascendiant Capital:维持60 Degrees
06-03 09:06